Mito.newsMito.news
← All articlesEditorial brief · abstract-levelScore 29/100Confidence medium
biorxiv2026-07-28therapeuticscancer

Mitos importance brief: Doxycycline Modulates Uveal-Melanoma-Associated Marker Expression in BAP1-Repressed Human Ocular Organoids

This biorxiv preprint matters for mitochondria agents because it engages therapeutics, cancer. Dysfunction-adjacent signals: cancer.

Mito.news · at a glance

Signal profile (abstract-level)

therapeutics · cancer

Score 29/100BIORXIVmedium confidencetherapeutics
29
Importance
50
Mito signal
39
Dysfunction
83
Evidence
93
Translational

Editorial signal profile from the abstract (importance score, mito keywords, dysfunction tags, evidence density, translational cues). Not a figure reproduced from the preprint PDF.

Importance thesis

This biorxiv preprint matters for mitochondria agents because it engages therapeutics, cancer. Dysfunction-adjacent signals: cancer.

Why research bots should care

Research bots need ranked importance commentary—not raw preprint dumps—so they can update literature maps without re-reading every abstract. This Mitos brief is the decision layer.

Mitochondrial context

Topics: therapeutics, cancer. Signals: cancer. Uveal Melanoma (UM) is the most common eye cancer, with a metastatic mortality rate of 80%.

Key claims

  • Doxycycline has recently been shown to inhibit metabolic processes exploited by cancer cells and reduce cancer cell growth in models of liver cancer.
  • We hypothesized doxycycline may also be effective in UM and therefore tested doxycycline treatment in an eye organoid model of uveal melanoma.
  • Using a stem cell line whereby BAP1 can be knocked down with a tetracycline-inducible system, we differentiated this line into a whole eye organoid model termed self-formed ectodermal autonomous multi-zone of ocular cells (SEAM).
  • We found an enhanced proliferation in neural crest cells within the SEAM colonies.
  • To identify the neural crest cells, we conducted single-cell RNA sequencing (scRNA-seq) analysis utilizing the Seurat R toolkit to pinpoint genes within neural crest clusters.

Methods snapshot

Doxycycline has recently been shown to inhibit metabolic processes exploited by cancer cells and reduce cancer cell growth in models of liver cancer. We hypothesized doxycycline may also be effective in UM and therefore tested doxycycline treatment in an eye organoid model of uveal melanoma.

Limitations

  • Preprint — not peer-reviewed.
  • Based on title + abstract only.
  • Heuristic editorial mode (no LLM).

Open questions

  • Does full-text design support the strongest abstract claim?
  • How does this interact with mitophagy / OXPHOS / mtDNA pathways?
  • Any contradictory preprints in the same window?

Agent takeaways

  • Index under: therapeutics, cancer.
  • Importance score 29/100.
  • Track claim: Doxycycline has recently been shown to inhibit metabolic processes exploited by cancer cells and reduce cancer cell growth in models of liver cancer.
  • Cite DOI 10.64898/2026.07.26.740828; Mitos sells commentary, not the paper license.

Source

  • Doxycycline Modulates Uveal-Melanoma-Associated Marker Expression in BAP1-Repressed Human Ocular Organoids
  • DOI: 10.64898/2026.07.26.740828
  • https://www.biorxiv.org/content/10.64898/2026.07.26.740828

Mitos original importance article. x402 product is this commentary.

Test bot purchase (MetaMask)

Free HTML is above. To pay for the same content as JSON (bot path), open the purchase tester:

Buy JSON with MetaMask ($0.005)

Bot URL: /api/v1/papers/10-64898-2026-07-26-740828

Source preprint

Doxycycline Modulates Uveal-Melanoma-Associated Marker Expression in BAP1-Repressed Human Ocular Organoids

10.64898/2026.07.26.740828

Chiu EA, Blenkinsop TA.

Related briefs